PERCEPTIVE ADVISORS LLC
CIK 1224962 · Holdings on Sep 30, 2023 · First reported Nov 14, 2023
Top ten holdings
Q3 2023- 03152W10911.32%
- 15678U1287.40%
- IMVT4.92%
- ACLX4.78%
- NUVL3.81%
- SLNO3.05%
- LIANY2.88%
- AKRO2.75%
- INBX2.63%
- ALDX2.55%
Share classes counted separately46.09%
Portfolio value by quarter
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | 03152W109AMICUS THERAPEUTICS INC View history and evidence | $336.75M | 11.32% | 27.69M shares | — | ↗▾ | |
| 02 | 15678U128CEREVEL THERAPEUTICS HOLDING View history and evidence | $220.23M | 7.40% | 10.09M shares | — | ↗▾ | |
| 03 | IMVTIMMUNOVANT INC View history and evidence | $146.45M | 4.92% | 3.81M shares | — | ↗▾ | |
| 04 | ACLXARCELLX INCCOMMON STOCK View history and evidence | $142.30M | 4.78% | 3.97M shares | — | ↗▾ | |
| 05 | NUVLNUVALENT INC-A View history and evidence | $113.24M | 3.81% | 2.46M shares | — | ↗▾ | |
| 06 | SLNOSOLENO THERAPEUTICS INC View history and evidence | $90.73M | 3.05% | 3.07M shares | — | ↗▾ | |
| 07 | LIANYLIANBIO-ADRSPONSORED ADS View history and evidence | $85.76M | 2.88% | 57.56M shares | — | ↗▾ | |
| 08 | AKROAKERO THERAPEUTICS INC View history and evidence | $81.91M | 2.75% | 1.62M shares | — | ↗▾ | |
| 09 | INBXINHIBRX INC View history and evidence | $78.10M | 2.63% | 4.26M shares | — | ↗▾ | |
| 10 | ALDXALDEYRA THERAPEUTICS INC View history and evidence | $75.82M | 2.55% | 11.35M shares | — | ↗▾ |
Options overlay 10
$23.51M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
AKROAKERO THERAPEUTICS INC View history and evidence | Call | 800.00K | $5.46M | ▾ | |
NVAXNOVAVAX INCCOM NEW View history and evidence | Put | 1.30M | $3.77M | ▾ | |
SRPTSAREPTA THERAPEUTICS INC View history and evidence | Call | 100.00K | $3.13M | ▾ |
3 / 10 options · preview only
Exited positions 15
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| APLS APELLIS PHARMACEUTICALS INC | Non-derivative | — | — | SEC filing ↗ | |
| RETA REATA PHARMACEUTICALS INC-A | Non-derivative | — | — | SEC filing ↗ | |
| VIR VIR BIOTECHNOLOGY INC | Non-derivative | — | — | SEC filing ↗ |
3 / 15 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1224962 · Period 2023-09-30
Data loaded 2026-09-23 · First reported 2023-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 2997910052
}Research all 97 reported holdings.
This page includes 30 of 97 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 97 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1224962","quarter":"2023Q3","page_size":100}
get_institutional_manager_history
{"cik":"1224962","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.